Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03221413 : Transcranial Alternating Current for Oscillopathies
PhaseN/A
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- PD: diagnosis of idiopathic PD within the last 5 years (UK Brain Bank criteria);
stable dose of antiparkinson therapy for at least 4 weeks; total off-medication motor
Hoen and Yahr 1-2.

- NP: stable chronic pain for at least the preceding six months; score greater than or
equal to 3 (0 no pain, 10 worst pain) on the visual analog scale (VAS) for pain
perception during the last month before start of stimulation; refractoriness to drugs
for pain relief (pain resistance to at least two of these drugs supplied in adequate
dosages for 6 months).

Exclusion Criteria:

- PD: concomitant psychiatric disorder; benzodiazepine treatment; Mini Mental State
Examination (MMSE) <26

- NP: clinically significant or unstable medical or psychiatric disorder, history of
substance abuse
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT03221413      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740